News

Allot Ltd. Reports Impressive Growth in Q3 Financials

Allot Ltd. Reports Impressive Growth in Q3 Financials

Allot Reports Third Quarter Financial Results

60% YoY SECaaS ARR growth alongside strong profitability; adjusting revenue forecast upward.

Allot Ltd. (NASDAQ: ALLT), a prominent provider of Security-as-a-Service (SECaaS) and network intelligence solutions, has released its financial results for the third quarter of 2025, showcasing a remarkable performance driven by enhanced cybersecurity solutions and network intelligence capabilities.

Key Financial Highlights

The company reported revenues totaling $26.4 million, representing a 14% increase from the previous year. Notably, SECaaS now accounts for 28% of the overall revenue, indicating a solid commitment to this growing sector.

As of September 2025, the SECaaS Annual Recurring Revenue (ARR) reached $27.6 million, marking a significant 60% increase compared to the previous year's figures. Allot achieved a GAAP operating income of $2.2 million, a turnaround from a loss of $0.2 million in the same quarter last year.

Allot’s non-GAAP operating income also increased to $3.7 million, surpassing the $1.1 million reported for Q3 2024. The company displayed strong positive operating cash flow of $4.0 million, with total cash reserves amounting to $81 million.

CEO Statement

Eyal Harari, CEO of Allot, expressed enthusiasm regarding the company’s performance, stating, "We are pleased to see a return to double-digit year-over-year revenue growth. Our operations produced the highest profitability we have seen in over ten years. This growth is a result of the effective deployment of our cybersecurity solutions and network intelligence offerings.”

He emphasized the importance of supporting customers in achieving their business objectives, which underpins Allot's strategy to foster profitable growth moving forward.

Mr. Harari further added, "With our SECaaS growth remaining strong, we anticipate our ARR growth rate year-over-year will exceed 60%. Therefore, we are raising our full-year revenue guidance to a range of $100-103 million.”

Financial Summary for Q3 2025

In detail, the total revenues of $26.4 million exhibited a 14% increase from $23.2 million in Q3 2024. The gross profit according to GAAP was $18.9 million, achieving a gross margin of 71.4%, an increase from a gross margin of 70.4% in the same quarter the prior year.

The non-GAAP gross profit rose to $19.1 million, reflecting a gross margin of 72.2%, which is a 14% increase from the previous year’s $16.7 million.

Allot declared net income on a GAAP basis of $2.8 million, translating to earnings of $0.07 per diluted share, improving from a net loss of $0.2 million, or loss of $0.01 per basic share, in Q3 2024. The non-GAAP net income jumped to $4.6 million, or $0.10 per diluted share, compared to a non-GAAP net gain of $1.3 million, or $0.03 per diluted share, reported in the same quarter a year ago.

Allot also reported that its cash flow for the quarter stood at $4.0 million. The total cash reserves, which include net cash and cash equivalents, bank deposits, along with other restricted deposits and investments, were recorded at $81 million. This marks an increase of $22 million against December 31, 2024, where they were valued at $59 million. Notably, the company is free from any debt.

Investor Conference Call Details

Allot’s management has scheduled a conference call to discuss the financial results for Q3 2025. This call will take place today at 9:00 am ET, 4:00 pm Israel time. Interested parties can access the call through the following numbers:

US: 1-888-668-9141, UK: 0-800-917-5108, Israel: +972-3-918-0644

A live webcast will be available on the Allot website, with an archived version accessible post-call.

About Allot Ltd.

Allot Ltd. (NASDAQ: ALLT) specializes in delivering advanced converged cybersecurity solutions and network intelligence services for service providers and enterprises globally. Allot aims to enhance customer value through solutions deployed worldwide. They focus on providing network-native cybersecurity services as well as analytics, traffic control, and more. Over 500 service providers and 1,000 enterprises utilize Allot’s leading multi-service platforms.

To learn more about Allot, please visit www.allot.com.

Frequently Asked Questions

What are the key financial highlights for Allot in Q3 2025?

Allot reported $26.4 million in revenues, a 14% increase year-over-year, with SECaaS ARR growing by 60% to $27.6 million.

Who is the CEO of Allot, and what did they say about the results?

Eyal Harari is the CEO, and he noted a return to double-digit revenue growth and raised revenue guidance due to strong performance in cybersecurity and network intelligence.

What was Allot's operating income for Q3 2025?

The GAAP operating income was $2.2 million, a turnaround from a loss of $0.2 million in Q3 2024.

What are Allot's future revenue projections?

Allot anticipates an ARR growth rate exceeding 60% and raised its revenue forecast to between $100-103 million for the full year.

How has Allot prepared for future growth?

Allot continues to invest in cybersecurity solutions, with a focus on helping clients achieve their business outcomes, driving overall profitability.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 405

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 80

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Prodigy Processing Solutions Leads the Charge in Cannabis Extraction

Updated Category News Views 240

Prodigy Processing Solutions Steps into New York's Cannabis Scene Prodigy Processing Solutions is making strides in the cannabis industry by teaming up with ProXtracts Processing Inc., a leading cannabis oil producer, to initiate a pioneering hydrocarbon extraction lab. This collaboration highlights Prodigy's commitment to providing top-notch extraction technologies while...

Continue Reading
Key Details for Moderna Investors Regarding Class Action

Updated Category News Views 69

Important Information for Moderna, Inc. Investors The Gross Law Firm has an important update for shareholders of Moderna, Inc. (NASDAQ: MRNA). If you've purchased shares during the specific class period, you're encouraged to reach out to the firm about possibly serving as lead plaintiffs in an upcoming class action lawsuit. Class Period and Lead Plaintiff Information If...

Continue Reading
Vistagen Therapeutics Investors: Important Legal Update Ahead

Updated Category News Views 117

Vistagen Therapeutics' Legal Challenges: A Summary for Investors As a prominent player in the therapeutic landscape, Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is currently navigating significant legal challenges that investors should be aware of. Legal representation is crucial for those who have invested in the company's stock, particularly following the announcement of...

Continue Reading
Nilfisk Holding A/S Unveils Key 2025 Financial Dates

Updated Category News Views 494

Nilfisk Holding A/S Financial Calendar for 2025 Nilfisk Holding A/S stands out as a prominent global player in the professional cleaning industry, consistently delivering high-quality products and services. As the new year approaches, the company has set forth significant dates for financial disclosures that are vital for investors and stakeholders alike. Upcoming Key...

Continue Reading
Exciting Return of Twang’s Signature Beer and Pickle Salts

Updated Category News Views 332

Exciting Announcement from Twang Twang, a beloved Latino-founded brand, has once again captured the hearts of flavor enthusiasts. Known for its innovative and enticing blends of flavored salts, Twang is thrilled to share the return of two highly anticipated products: Orange Beer Salt and Hot Pickle Flavored Salt. Fans of these tasty seasonings can look forward to their...

Continue Reading